IGF-1R, EGFR, and VEGF can bind to RTKs, which will activate RAS-RAF-MAPK and PI3K/AKT/mTOR signaling pathways, promoting tumor growth, progression, cell survival, motility, and invasion. The gene discussed is PIK3CA; the disease is neoplasm.